
Ac-Pro Spot Repairing Treatment
💧 3-in-1 Spot, Brightening & Moisturizing Care – An all-over treatment that targets acne, dark spots, and dehydration for clear, healthy skin without irritation.
🌱 Soothes Early Redness & Inflammation – Calming formula with allantoin, zinc, and madecassoside helps reduce redness overnight and soothes irritated skin fast.
✨ Improves Pigmentation & Blemish Marks – Clinically proven to brighten both outer and inner skin pigmentation areas after 4 weeks of use.
🌸 Dual Acne-Fighting System (LHA + AC-PRO Complex) – LHA (Capryloyl Salicylic Acid) gently exfoliates dead skin and sebum, while AC-PRO Complex clears clogged pores and supports a smooth, balanced complexion.
💦 Non-Sticky Moisturizing Finish – Enriched with panthenol and beta-glucan to lock in moisture, leaving skin soft, hydrated, and refreshed.
🔬 Clinically Tested for Acne-Prone Skin – Shown to reduce inflammatory acne by 21.9% and non-inflammatory lesions by 12.6% in 4 weeks (Elid Clinical Center Study, 2022).
Original: $25.99
-65%$25.99
$9.10Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
💧 3-in-1 Spot, Brightening & Moisturizing Care – An all-over treatment that targets acne, dark spots, and dehydration for clear, healthy skin without irritation.
🌱 Soothes Early Redness & Inflammation – Calming formula with allantoin, zinc, and madecassoside helps reduce redness overnight and soothes irritated skin fast.
✨ Improves Pigmentation & Blemish Marks – Clinically proven to brighten both outer and inner skin pigmentation areas after 4 weeks of use.
🌸 Dual Acne-Fighting System (LHA + AC-PRO Complex) – LHA (Capryloyl Salicylic Acid) gently exfoliates dead skin and sebum, while AC-PRO Complex clears clogged pores and supports a smooth, balanced complexion.
💦 Non-Sticky Moisturizing Finish – Enriched with panthenol and beta-glucan to lock in moisture, leaving skin soft, hydrated, and refreshed.
🔬 Clinically Tested for Acne-Prone Skin – Shown to reduce inflammatory acne by 21.9% and non-inflammatory lesions by 12.6% in 4 weeks (Elid Clinical Center Study, 2022).














